Clinical Trials Logo

Filter by:
NCT ID: NCT05572437 Recruiting - Postoperative Pain Clinical Trials

Perioperative Effect of Music in Patients Undergoing General Anesthesia

EMBAG
Start date: October 15, 2022
Phase: N/A
Study type: Interventional

Anxiety is a transient emotional state characterized by feelings of tension, apprehension, nervousness, fear, and heightened activation of the autonomic nervous system in response to a specific current or potential event or situation. Music therapy is a cost-effective and safe intervention applied to health care, that has been incorporated into different branches of medicine, including anesthesiology, showing economic benefits and as an adjunct to pharmacological therapy, allowing the use of lower doses of perioperative drugs, thus reducing their deleterious effects. The main objective of this randomized clinical trial is to evaluate whether the application of music during the perioperative period reduces perioperative anxiety in patients undergoing general and digestive surgery under general anesthesia.Patients between 18 and 60 years of age, classified according to the American Society of Anesthesiologists (ASA) I-IV, scheduled for general surgery and who have signed the informed consent, will be randomized to receive music therapy in the immediate perioperative period or not. Perioperative anxiety, stay in the PACU, incidence of postoperative pain and intraoperative opioid consumption will be compared between both groups.

NCT ID: NCT05572073 Recruiting - Clinical trials for Sensorineural Hearing Loss, Bilateral

Otoferlin Gene-mediated Hearing Loss Natural History Study

Start date: July 14, 2022
Phase:
Study type: Observational

This is a retrospective and prospective longitudinal study in participants with Otoferlin Gene-Mediated Hearing Loss.

NCT ID: NCT05571449 Recruiting - Clinical trials for Tibial Plateau Fracture

Efficacy of the Use of 3D Printing Models in the Treatment of Tibial Plateau Fractures: a Randomized Clinical Trial

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

TIBIA3D is a randomized, open and prospective clinical trail that evaluates the use of preoperative 3D printing in the surgical treatment of patients with tibial plateau fractures

NCT ID: NCT05571124 Recruiting - Back Pain Clinical Trials

Workplace Exercise Intervention in Administrative Personnel to Reduce Spinal Pain

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

The goal of this Clinical trial is to compare treatments in sedentary administrative personnel with back pain. The main question it aims to answer: The benefits of a workplace intervention with therapeutic exercise and pain education compared with only therapeutic exercise intervention Participants will perform active pauses in their workplace with a web-based program that consists of videos or images of exercises and pain education information. Researchers will compare a group Therapeutic exercise and pain education intervention with a group therapeutic exercise only to see if pain education plus exercise is a more beneficial intervention in reducing back pain in symptomatic administrative personnel.

NCT ID: NCT05570058 Recruiting - Fibrosis Clinical Trials

Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis

Start date: September 8, 2022
Phase: Phase 2
Study type: Interventional

The purpose of the study is to assess the safety and tolerability of RXC007 when given for 12 weeks (84 days), alone and in combination with nintedanib or pirfenidone.

NCT ID: NCT05569161 Recruiting - Clinical trials for Implantation of a Reverse Shoulder Prosthesis

To Evaluate the Safety and Clinial Radiological Outcomes in 2 Years of Embrance Model Reverse Shoulder Arthroplasty

Start date: March 24, 2022
Phase:
Study type: Observational

The use of inverted prostheses to replace shoulder joints damaged by degenerative or traumatic processes has become widespread over the past three decades. Current designs, used correctly, can restore function and improve pain in the majority of patients in whom they are implanted. However, there are complications associated with shoulder arthroplasty surgery, such as wear of the prosthetic components, infection, allergy to the prosthetic components, or failure to restore full shoulder function. The occurrence of these complications is affected by multiple factors dependent on the subject, the surgeon and/or the implant used. The EMBRACE Reverse Shoulder Arthroplasty System (LINK Spain) is a new model of reverse shoulder prosthesis introduced to the European market in August 2020. It is authorised for use in the treatment of degenerative or traumatic processes of the shoulder in the European Community. It has been in regular use at our centre since October 2020, and more than 50 prostheses of this model have been implanted this year. There is an ongoing study at the Hospital Universitario Ramón y Cajal, with code PROTESISHOMBRO01, which carries out a prospective registry of all shoulder prostheses implanted at the centre. The present study, PROTESISHOMBRO02, will be carried out in conjunction with this one and differs from the previous one in that: 1.-It carries out a somewhat more exhaustive analysis of a subgroup of the patients included in the PROTESISHOMBRO01 study, and 2. The aim is to carry out a more detailed follow-up of the subjects who are implanted with this prosthetic model on a primary basis, analysing the clinical and radiological results and evaluating the presence of adverse effects of the prosthesis or short-term complications. For this purpose, subjects will be closely monitored for two years.

NCT ID: NCT05568706 Recruiting - RSV Infection Clinical Trials

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

RSVHR
Start date: November 29, 2022
Phase: Phase 2
Study type: Interventional

This is a Phase 2b, randomized, double-blind, placebo-controlled study of EDP-938 administered orally for the treatment of non-hospitalized adult subjects with confirmed RSV infection who are at high risk for complications after RSV infection.

NCT ID: NCT05568524 Recruiting - Hemophilia Clinical Trials

Resistance Training With Blood Flow Restriction in Hemophilia

HemoBFR
Start date: January 15, 2024
Phase: N/A
Study type: Interventional

The main objectives of this study are to evaluate safety and chronic effects of a low-load resistance exercise intervention (elbow flexions and extensions, and knee extensions) with blood flow restriction in people with hemophilia on quality of life, pain, and on physical and neuromuscular function.

NCT ID: NCT05566938 Recruiting - Aging Clinical Trials

Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly

NUTRIMET
Start date: September 5, 2022
Phase: N/A
Study type: Interventional

From a public health point of view, personalized nutritional recommendations, at the individual level, are difficult to achieve in the short-medium term, especially in population segments with less purchasing power. Therefore, a more realistic vision in the short term and with a more favourable cost/effectiveness ratio consists of carrying out dietary advice at the group level through the identification of metabotypes, which can be defined as groups of individuals with similar metabolic profiles. The application of tailored precision nutrition aimed at the elderly is detected as a strategy to understand the different alterations associated to aging and to design innovative nutritional interventions that address this physiological process, favouring a healthy ageing.

NCT ID: NCT05566795 Recruiting - Low-grade Glioma Clinical Trials

DAY101 vs. Standard of Care Chemotherapy in Pediatric Patients With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)

Start date: February 27, 2023
Phase: Phase 3
Study type: Interventional

This is a 2-arm, randomized, open-label, multicenter, global, Phase 3 trial to evaluate the efficacy, safety, and tolerability of tovorafenib monotherapy versus standard of care (SoC) chemotherapy in patients with pediatric low-grade glioma (LGG) harboring an activating rapidly accelerated fibrosarcoma (RAF) alteration requiring front-line systemic therapy.